% of cells staining | Number of women | Number of deaths | Adjusted HR (95% CI) | |
---|---|---|---|---|
Model 1a | Model 2b | |||
Overall | Â | Â | Â | Â |
<1 (ER-negative) | 506 | 157 | Referent | Referent |
≥1 (ER-positive) | 698 | 115 | 0.53 (0.41 to 0.68) | 0.64 (0.48 to 0.85) |
1 to 39 | 117 | 27 | 0.81 (0.53 to 1.24) | 0.93 (0.60 to 1.43) |
40 to 59 | 118 | 18 | 0.55 (0.34 to 0.91) | 0.66 (0.39 to 1.12) |
60 to 79 | 193 | 31 | 0.50 (0.33 to 0.74) | 0.57 (0.38 to 0.88) |
80 to 100 | 270 | 39 | 0.43 (0.30 to 0.62) | 0.52 (0.35 to 0.78) |
Trend |  |  | Ptrend <0.0001 | Ptrend = 0.0003 |
Trend in women with ER-positive tumors only |  |  | Ptrend = 0.004 | Ptrend = 0.006 |
Per 10% increase | Â | Â | 0.92 (0.89 to 0.95) | 0.94 (0.91 to 0.97) |
Per 10% increase in women with ER-positive tumors only | Â | Â | 0.91 (0.84 to 0.99) | 0.91 (0.84 to 0.99) |
White women | Â | Â | Â | Â |
<1 (ER-negative) | 251 | 69 | Referent | Referent |
≥1 (ER-positive) | 430 | 62 | 0.42 (0.29 to 0.61) | 0.56 (0.36 to 0.87) |
1 to 39 | 75 | 18 | 0.81 (0.46 to 1.43) | 1.04 (0.57 to 1.91) |
40 to 59 | 66 | 10 | 0.46 (0.22 to 0.94) | 0.65 (0.30 to 1.43) |
60 to 79 | 123 | 17 | 0.37 (0.21 to 0.66) | 0.47 (0.25 to 0.86) |
80 to 100 | 166 | 17 | 0.28 (0.16 to 0.50) | 0.39 (0.21 to 0.73) |
Trend |  |  | Ptrend <0.0001 | Ptrend = 0.0004 |
Trend in women with ER-positive tumors only |  |  | Ptrend = 0.001 | Ptrend = 0.002 |
Per 10% increase | Â | Â | 0.88 (0.84 to 0.93) | 0.91 (0.86 to 0.96) |
Per 10% increase in women with ER-positive tumors only | Â | Â | 0.85 (0.76 to 0.96) | 0.86 (0.76 to 0.96) |
Black women | Â | Â | Â | Â |
<1 (ER-negative) | 255 | 88 | Referent | Referent |
≥1 (ER-positive) | 268 | 53 | 0.56 (0.39 to 0.81) | 0.62 (0.42 to 0.94) |
1 to 39 | 42 | 9 | 0.56 (0.28 to 1.15) | 0.63 (0.30 to 1.29) |
40 to 59 | 52 | 8 | 0.50 (0.24 to 1.06) | 0.55 (0.25 to 1.21) |
60 to 79 | 70 | 14 | 0.60 (0.33 to 1.08) | 0.65 (0.35 to 1.21) |
80 to 100 | 104 | 22 | 0.56 (0.34 to 0.93) | 0.64 (0.37 to 1.10) |
Trend |  |  | Ptrend = 0.007 | Ptrend = 0.06 |
Trend in women with ER-positive tumors only |  |  | Ptrend = 0.54 | Ptrend = 0.67 |
Per 10% increase | Â | Â | 0.94 (0.90 to 0.98) | 0.95 (0.91 to 1.00) |
Per 10% increase in women with ER-positive tumors only | Â | Â | 0.98 (0.85 to 1.12) | 1.00 (0.87 to 1.14) |
Homogeneity between white women and black women | ||||
ER-positive versus ER-negative |  |  | Phomogeneity = 0.56 | Phomogeneity = 0.55 |
Trend |  |  | Phomogeneity = 0.13 | Phomogeneity = 0.12 |
Trend in women with ER-positive tumors only |  |  | Phomogeneity = 0.05 | Phomogeneity = 0.02 |
Per 10% increase |  |  | Phomogeneity = 0.16 | Phomogeneity = 0.15 |
Per 10% increase in women with ER-positive tumors only |  |  | Phomogeneity = 0.06 | Phomogeneity = 0.02 |